page-template,page-template-blog-large-image,page-template-blog-large-image-php,page,page-id-599,page-child,parent-pageid-1815,strata-core-1.1,strata-theme-ver-3.3,ajax_fade,page_not_loaded,mob-menu-slideout-over,wpb-js-composer js-comp-ver-6.4.1,vc_responsive

Large Image

Duis aute irure dolor

First Treatment for ASMD approved by FDA

14:07 04 September in News

The US FDA has announced approving Xenpozyme (Olipudase alfa), for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD). The medication is the first to treat symptoms that are not related to the central nervous system in patients with ASMD. ASMD is...

Pharmacovigilance Free Webinar

12:35 17 August in News

One of the most evolving fields nowadays is pharmacovigilance . Want to know more about it? Register now in our #freewebinar on August 24, 2022 at 12:00 p.m. Lebanon time.For #registration, click the link below.👉🏻 https://bit.ly/3SFDigh #phoenixclinicalresearch #webinar #pharmacovigilance ...

Phoenix Clinical Research is looking for Head of Business Development

15:02 06 July in Uncategorized

Responsibilities: • Follows up new business opportunities and sets up meetings. • Plans and prepares presentations. • Establishes and maintains working relationships. • Supports the CEO. • Provides input to the development of marketing literature. • Provides management with market feedback • Maintains in-depth knowledge of all Phoenix CR services for appropriate...